Cart
sales@molnova.com
MAPK13-IN-1
CAS No. 229002-10-2
MAPK13-IN-1( —— )
Catalog No. M33008 CAS No. 229002-10-2
MAPK13-IN-1 is a potent MAPK13 (p38δ) inhibitor (IC50: 620 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 258 | In Stock |
|
| 2MG | 140 | In Stock |
|
| 5MG | 235 | In Stock |
|
| 10MG | 353 | In Stock |
|
| 25MG | 611 | In Stock |
|
| 50MG | 867 | In Stock |
|
| 100MG | 1265 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 2530 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMAPK13-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionMAPK13-IN-1 is a potent MAPK13 (p38δ) inhibitor (IC50: 620 nM).
-
DescriptionMPAK13-IN-1 is a MAPK13 (p38δ) inhibitor, with an IC50 of 620 nM.
-
In VitroCell Viability Assay Cell Line:Vero E6 cells.Concentration:0-100 μM.Incubation Time:Result:Exhibited an IC50 of 4.63 μM.
-
In Vivo——
-
Synonyms——
-
PathwayMAPK/ERK Signaling
-
Targetp38 MAPK
-
Recptorp38 MAPK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number229002-10-2
-
Formula Weight365.43
-
Molecular FormulaC20H23N5O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : ≥ 250 mg/mL (684.13 mM)
-
SMILESCn1nc(cc1NC(=O)Nc1ccc(Oc2ccncc2)cc1)C(C)(C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Yurtsever Z, et al. First comprehensive structural and biophysical analysis of MAPK13 inhibitors targeting DFG-in and DFG-out binding modes. Biochim Biophys Acta. 2016 Nov;1860(11 Pt A):2335-2344.?
molnova catalog
related products
-
SD-06
SD-06 is a p38 MAP kinase inhibitor, inhibits p38α with IC50 of 170 nM and inhibits LPS-stimulated TNF-release in rats.
-
Kamebakaurine
Kamebakaurin has the ability to protect the liver from APAP-induced hepatotoxicity, presumably by both inhibiting the inflammatory response and oxidative stress.
-
MW-150
MW-150 (MW01-18-150 SRM) is a novel potent, selective, CNS penetrant and orally active inhibitor of p38α MAPK with Ki of 101 nM.
